More than half of chronic rhinosinusitis with nasal polyps (CRSwNP) patients treated with dupilumab experience early and fast olfactory improvement within 28 days.

MLA

Otten, Josje Janna, et al. “More than Half of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Patients Treated with Dupilumab Experience Early and Fast Olfactory Improvement within 28 Days.” Allergy, vol. 79, no. 11, Nov. 2024, pp. 3166–68. EBSCOhost, https://doi.org/10.1111/all.16357.

APA

Otten, J. J., van der Lans, R. J. L., Elzinga, H. B. E., Adriaensen, G. F. J. P. M., Benoist, L. B. L., Hoven, R. D., Seys, S., Fokkens, W. J., & Reitsma, S. (2024). More than half of chronic rhinosinusitis with nasal polyps (CRSwNP) patients treated with dupilumab experience early and fast olfactory improvement within 28 days. Allergy, 79(11), 3166–3168. https://doi.org/10.1111/all.16357

Chicago

Otten, Josje Janna, Rik Johannes Leonardus van der Lans, Hester Beatrice Emilie Elzinga, Gwijde Flavius Jacobus Petrus Maria Adriaensen, Linda Berendina Laurentia Benoist, Rienk D. Hoven, Sven Seys, Wytske Johanna Fokkens, and Sietze Reitsma. 2024. “More than Half of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Patients Treated with Dupilumab Experience Early and Fast Olfactory Improvement within 28 Days.” Allergy 79 (11): 3166–68. doi:10.1111/all.16357.